The National Vaccine Institute (NVI) has launched a nationwide Vaccine Perception Survey as Ghana prepares to transition from support by Gavi, the Vaccine Alliance by 2030.
The initiative is part of efforts to strengthen public trust in locally manufactured vaccines and ensure long-term health security as the country works toward vaccine sustainability and sovereignty.
The survey, which began on February 16 and ends on March 10, 2026, is being conducted in 55 districts across all 16 regions.
It involves structured interviews with 11,077 respondents selected through random sampling, alongside seven focus group discussions to gather qualitative insights.
According to the NVI, the study will assess public attitudes toward vaccines, identify drivers of confidence, examine barriers to acceptance of Made-in-Ghana vaccines, and track misinformation trends that may undermine uptake.
Chief Executive Officer of the NVI, Sodzi Sodzi-Tettey, said the initiative is aimed at listening to communities and building trust.
“This is not a sales pitch. We genuinely want to listen and understand. The information provided is strictly confidential,” he stated.
The Institute noted that findings from the survey will inform communication strategies, guide region-specific interventions, and establish a national baseline for vaccine confidence as Ghana expands its vaccine manufacturing capacity.
Residents in the selected districts have been encouraged to participate, with the NVI assuring that all responses will remain confidential.
READ ALSO:
